The vital role of growth hormone in control of the COVID-19 pandemic era
Abstract
The COVID-19 pandemic is a worldwide pandemic challenge that started in China and spread to almost all countries. The causative virus was identified as highly contagious and, until now, significantly difficult to contain. Global epidemiological distribution has raised several questions whose answers could help us understand the behavior of the virus and consequently lead us to possible means of limiting its spread. Growth hormone (GH) secretion declines by approximately 15% for every decade of adult life in people after 30 years of age. Data from highly affected rural areas suggest a more aggressive course in the elderly, a double-time affection of males more than females. The deficiency of GH is a common sign in all susceptible patient groups. The role of GH in the exclusive epidemiological outline of the COVID-19 pandemic is vital so that it might help in the early identification and management of high-risk rural groups as appropriate.
References
Abs R, Mattsson A F, Thunander M, Verhelst J, Goth M I and Wilton P, et al. 2013. Prevalence of diabetes mellitus in 6050 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis. Eur J Endocrinol. 168: 297–305.
Allen D B, Backeljauw P, Bidlingmaier M, Biller B M, Boguszewski M and Burman P, et al. 2016. GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults. Eur J Endocrinol. 174: P1–9.
Alvarez P, Isidro L, Leal-Cerro A, Casanueva F F, Dieguez C and Cordido F, et al. 2002. Effect of withdrawal of somatostatin plus GH-releasing hormone as a stimulus of GH secretion in obesity. Clin Endocrinol. 56(4): 487–492.
Chao G, Cai Y, Zhang K, Zhou L, Zhang Y and Zhang X, et al. 2020. Association of hypertension and antihypertensive treatment with COVID-19 mortality: Retrospective observational study. Eur Heart J. 41(22): 2058–2066.
Clasey J L, Weltman A, Patrie J, Weltman J Y, Pezzoli S and Bouchard C, et al. 2001. Abdominal visceral fat and fasting insulin are important predictors of 24-hour GH release independent of age, gender, and other physiological factors. J Clin Endocrinol Metab. 86(8): 3845–3852.
Corbo G M, Di Marco Berardino A, Mancini A, Inchingolo R, Smargiassi A and Raimondo S, et al. 2014. Serum level of testosterone, dihydrotestosterone and IGF-1 during an acute exacerbation of COPD and their relationships with inflammatory and prognostic indices: a pilot study. Minerva Med. 105(4): 289–294.
Daniel H P T, Merriam G R. 2012. Endocrine hypertension: Underlying mechanisms and therapy. Hypertension in Growth Hormone Excess and Deficiency. July 7: 151–179.
Dong Y, Mo X and Hu Y, et al. 2020. Epidemiology of COVID-19 among children in China. Pediatrics 145(6): e20200702.
Elkarow M H and Hamdy A. 2020. A Suggested Role of Human Growth Hormone in Control of the COVID-19 Pandemic. Front. Endocrinol. 11:569633.
Feldt-Rasmussen U, Klose M, Feingold K R, Anawalt B, Boyce A and Chrousos G, et al. 2000. Adult growth hormone deficiency clinical management. In: Endotext, L J De Groot, G Chrousos, K Dungan, K R Feingold, A Grossman, J M Hershman, editors. South Dartmouth.
Funatsu M, Sato K and Mitani H. 2006. Effects of growth hormone on craniofacial growth. Duration of replacement therapy. Angle Orthod 76: 970-977.
Gelding S V, Taylor N F, Wood P J, Noonan K, Weaver J U and Wood D F, et al. 1998. The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11b-hydroxysteroid dehydrogenase activity. Clin Endocrinol. 48:153–162.
Giovannini L, Tirabassi G, Muscogiuri G, Di Somma C, Colao A and Balercia G. 2015. Impact of adult growth hormone deficiency on metabolic profile and cardiovascular risk. Endocr J. 62: 1037–1048.
Gotzinger F, Santiago-Garcia B, Noguera-Julian A, Lanaspa M, Lancella L,Calo and Carducci F I, et al. 2020. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. Lancet Child Adolesc Health. 4(9): 653-661.
Gupta S, Hayek S S, Wang W, Chan L, Mathews K S and Melamed M L, et al. 2020. Factors Associated with Death in Critically Ill Patients with Coronavirus Disease 2019 in the US. JAMA Intern Med. e203596.
Ho K Y and Weissberger A J. 1990. The antinatriuretic action of biosynthetic human growth hormone in man involves activation of the renin-angiotensin system. Metabolism 39: 133–137.
Huang I, Lim M A, Pranata R. 2020. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - A systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr. 14(4): 395–403.
Khudaiberdiev, S T. 2022. Hormonal function of adenohypophisis. The American Journal of Medical Sciences and Pharmaceutical Research, 4(02): 33–37.
Kim S H and Park M J. 2017. Effects of growth hormone on glucose metabolism and insulin resistance in human. Ann Pediatr Endocrinol Metab. 22: 145–152.
Kumar A, Nayar K R and Koya S F. 2020. COVID-19: Challenges and its consequences for rural health care in India. Public Health in Practice 1: 100009.
Kythreotis P, Kokkini A, Avgeropoulou S, Hadjioannou A, Anastasakou E and Rasidakis A, et al. 2009. Plasma leptin and insulin-like growth factor I levels during acute exacerbations of chronic obstructive pulmonary disease. BMC Pulm Med. 9: 11.
Lanfranco F, Motta G, Minetto M A, Ghigo E and Maccario M. 2010. Growth hormone/ insulin-like growth factor-I axis in obstructive sleep apnea syndrome: An update. J Endocrinol Invest. 33: 192–196.
Leger J, Noel M, Limal J M and Czernichow P. 1996. Growth factors and intrauterine growth retardation. II. Serum growth hormone, insulin-like growth factor (IGF) I, and IGF-binding protein 3 levels in children with intrauterine growth retardation compared with normal control subjects: prospective study from birth to two years of age. Study Group of IUGR. Pediatr Res. 40(1): 101–107.
Mehta N, Kalra A, Nowacki A S, Anjewierden S, Han Z and, Bhat P, et al. 2020. Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19). JAMA Cardiol. 5(9): 1020–1026.
Merriam G R and Hersch E C. 2008. Growth hormone (GH)-releasing hormone and GH secretagogues in normal aging: Fountain of Youth or Pool of Tantalus. Clin Interv Aging 3(1): 121–129.
Mo G, Hu B, Wei P, Luo Q and Zhang X. 2022. The role of chicken prolactin, growth hormone and their receptors in the immune system. Front Microbiol. 13: 900041.
Munoz M C, Burghi V, Miquet J G, Giani J F, Banegas R D and Toblli J E, et al. 2014. Downregulation of the ACE2/ Ang-(1-7)/ Mas axis in transgenic mice overexpressing GH. J Endocrinol. 221(2): 215–27.
Ni W, Yang X, Yang D, Bao J, Li R and Xiao Y, et al. 2020. Role of angiotensin converting enzyme 2 (ACE2) in COVID-19. Crit Care 24: 422.
Ottesen L H, Bendtsen F and Flyvbjerg A. 2001. The insulin-like growth factor binding protein 3 ternary complex is reduced in cirrhosis. Liver 21: 350–356.
Paramasivam R, Yuggheshinie M, Mohammed E, Fauzi M and Akhmazillah N. 2022. Development of human growth hormones. In: Chemical Process and Sustainability in Medical Biotechnology. Penerbit UTHM, UTHM, pp. 75-88.
Peng X, Xu X, Li Y, Cheng L, Zhou X and Ren B. 2020. Transmission routes of 2019-nCoV and controls in dental practice. Int J Oral Sci.12(1): 9.
Rajkovic I, Valiontis E and Ho K K Y. 1994. Direct quantitation of growth hormone binding protein in human serum by a ligand immunofunctional assay: comparison with immunoprecipitation and chromatographic methods. J Clin Endocrinol Metab. 78: 772–777.
Reid A. 2005. The Effects of the 1918–1919 Influenza Pandemic on Infant and Child Health in Derbyshire. Med History 49(1): 29–54.
Salehzadeh M, Hamden J E, Li M X, Bajaj H, Wu R S and Soma K K. 2022. Glucocorticoid Production in Lymphoid Organs: Acute Effects of Lipopolysaccharide in Neonatal and Adult Mice. Endocrinology. 163(2): bqab244.
Santos R, Sampaio W, Alzamora A, Motta-Santos D, Alenina N and Bader M, et al. 2018. The ACE2/ angiotensin-(1-7)/ MAS axis of the renin-angiotensin system: focus on angiotensin-(1-7). Physiol Rev. 98: 505–53.
Savino W, Postel-Vinay M C, Smaniotto S and Dardenne M. 2002. The Thymus Gland: a Target Organ for Growth Hormone. Immunology. 55(5): 442-452.
Sherlock M and Toogood A A. 2007. Aging and the growth hormone/insulin like growth factor-I axis. Pituitary 10(2): 189–203.
Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J and Duhamel A, et al. 2020. High Prevalence of Obesity in Severe Acute Respiratory Syndrome coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation. Obes. 28(7): 1195–1199.
Stewart P M, Toogood A A and Tomlinson J W. 2001. Growth hormone, insulin-like growth factor-I and the cortisol-cortisone shuttle. Horm Res. 56 Suppl (1): 1–6.
Tong R, Pan L, Xin Z and Li Y. 2022. Neuroendocrine-immune regulation mechanism in crustaceans: A review. Aquaculture. Volume14(1): 378-398.
Vahl N, Jorgensen J O, Jurik A G and Christiansen J S. 1996. Abdominal adiposity and physical fitness are major determinants of the age associated decline in stimulated GH secretion in healthy adults. J Clin Endocrinol Metab 81(6): 2209–2215.
Verity R, Okell L C, Dorigatti I, Winskill P, Whittaker C and Imai N, et al. 2020. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 20(6): P669–677.
WHO. 2020. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). 16-20th February 2020: Major findings, chapter 2, page12. World health organization.
WHO. 2020a. Clinical Management of Severe Acute Respiratory Infection when Novel Coronavirus (2019-nCoV) Infection is Suspected: Interim Guidance. World Health Organization, Geneva, Switzerland. Clinical-management-of-covid-19. Accessed June 1.
WHO. 2020b. Coronavirus Disease 2019 (COVID-19): Situation Report, 46. World Health Organization, Geneva, Switzerland. Accessed June 1.
WHO. 2020c. Infection Prevention and Control During Health Care when Novel Coronavirus (nCoV) Infection is Suspected: Interim Guidance. World Health Organization, Geneva, Switzerland. Accessed June 1.
